Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Technical Fix For Medicaid AMP Definition Would Cost Pharma Firms $2.1 Bil. Over 10 Years, CBO Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The Senate is considering a provision to fix health care reform law language on calculating average manufacturer prices for Medicaid rebates.
Advertisement

Related Content

Medicare And Medicaid In Brief
Medicare And Medicaid In Brief
Inpatient Drug Discounts For 340B Providers Resurface In Jobs Bill
Inpatient Drug Discounts For 340B Providers Resurface In Jobs Bill
Zero Medicaid Rebate For Specialty Rx? Reform Law Puts CMS In Conundrum

Topics

Advertisement
UsernamePublicRestriction

Register

PS070817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel